Activity Description
The webcast is comprised of proceedings from the Heart Rhythm 2018 symposium, Stroke Prevention in Atrial Fibrillation: Advancements in Oral Anticoagulation Therapy and LAA Closure
Access Presentations
Complimentary Access
We are pleased to provide complimentary and unlimited access to the on-demand video library from SPAF 2018.
To view, click on the presentation titles listed below.
|
Opening Remarks |
|
Session I |
|
Watchman Implantation: Tips and Tricks |
|
Pericardial Effusion: Incidence, Timing & Management |
|
Mortality and Net Clinical Benefit: New Analyses from the Watchman RCTs |
|
Watchman Implantation: Recorded Case |
|
Session II |
|
NOAC Use in “Special Populations”: CKD, Liver Disease, Obesity, Elderly |
|
Using NOAC Reversal Agents: When and How? |
|
Understanding Intracranial Hemorrhage Risk before It Happens |
|
Non-Cardioembolic Stroke: Incidence in AF Patients& Prevention (OACs vs Antiplatelets) |
|
Real-World Registry NOAC Outcomes: Relative Effectiveness & Compliance |
|
Panel Discussion |
|
Session III |
|
Watchman Clinical Trial Update |
|
Update on Amulet Clinical Trials |
|
AtriClip: Recorded Case & Outcomes |
|
LAAC Device Potpourri (Wavecrest / Lambre): What Would the Ideal Device Look Like? |
|
Panel Discussion |
|
Session IV |
|
Subclinical Atrial Fibrillation: Incidence and Management |
|
Identifying AF with Consumer Devices: Hope or Hype? |
|
MR Imaging for Risk Stratification of Stroke in AF |
|
ILRs to Identify AF in High-Risk Individuals: Insights from REVEAL AF |
|
Panel Discussion |
|
Session V |
|
Peri-Device Leaks: Incidence, Outcomes & Management |
|
Coil Embolization of Peri-Device Leaks: Technique and Results |
|
Device-Related Thrombus: Incidence, Management & Outcomes |
|
Watchman-Flex Implantation: Recorded Case |
|
Session VI |
|
LAAC Device Embolization – Incidence, Outcomes, Management |
|
An Unusual Case: Late Removal of a Malpositioned LAAC Device |
|
Minimizing Device-Related Thrombus: Strategies to Consider |
|
LAAC Strategies in the Patient with an Active LAA Thrombus |
|
Late Stroke after LAAC: How do I evaluate the Patient? |
|
Panel Discussion |
|
Session VII |
|
Multicenter LAAC RCTs: Ongoing Trials & What is Needed? |
|
Stroke Prevention Trial Endpoints: What are both persuasive and practical? |
|
LAAC in Contraindicated Patients |
|
Initial Outcomes from the NCDR LAAC Registry |
|
Outcomes of Surgical LAAC: What is known? What will LAAOS III tell us? |
|
Panel Discussion |
|
Session VIII |
|
Percutaneous Carotid Coil Filters: A Novel Approach to Stroke Prevention? |
|
Combining LAAC with AF Ablation |
|
Combining LAAC with Percutaneous Valve Procedures |
|
Panel Discussion |
Faculty
|
Program Chair |
||
| Vivek Reddy, MD The Mount Sinai Hospital New York, NY |
||
|
Faculty |
||
|
Lucas Boersma, MD, PhD John Camm, MD Andre d'Avila Luigi Di Biase, MD, PhD Shephal Doshi, MD Srinivas Dukkipati, MD Gan Dunnington, MD Christopher Ellis, MD Douglas Gibson, MD Taya Glotzer, MD Edip Gurol, MD Jonathan Halperin, MD Rodney Horton, MD Jonathan Hsu, MD Elaine Hylek, MD Samir Kapadia, MD Jamie Kim, MD, FACC Dhanunjaya Lakkireddy, MD |
Thorsten Lewalter, MD Daniel Lustgarten, MD Moussa Mansour, MD Andrea Natale, MD Petr Neuzil, MD, PhD Douglas Packer, MD Jonathan Piccini, MD Jeremy Ruskin, MD Boris Schmidt, MD Sheldon Singh, MD Vijay Swarup, MD, FACC, FHRS Mintu Turakhia, MD Paul Varosy, MD Atul Verma, MD Oussama Wazni, MD William Whang, MD
|
Objectives
Activity Description
This on-demand webcast was created from the proceedings of the Symposium on Stroke Prevention in Atrial Fibrillation: Advancements in Oral Anticoagulation Therapy and LAA Closure. This activity features world-renowned faculty experts, who explore the most recent advancements and developments in LAAC and oral anticoagulation therapy for managing AF related stroke. The webcast showcases LAAC cases from leading institutions, insightful rapid-fire presentations, expert panel discussions, and engaging Q&A sessions.
Target Audience
This activity has been developed to meet the educational needs of electrophysiologists, interventional cardiologists, cardiologists, surgeons, and other physicians and associated healthcare professionals with an interest in the management of stroke in AF patients.
Learning Objectives
Upon completion of this educational activity, participants will be able to:
- Identify how to use and reverse NOACs.
- Discuss the role of the Left Atrial Appendage (LAA) in AF-related strokes.
- Evaluate novel oral anticoagulation and advancements in Left Atrial Appendage Closure (LAAC) for stroke prophylaxis in AF.
- Review strategies for balancing stroke vs bleeding in clinical practice.
- Examine randomized clinical trial and registry data.
- Review appropriate NOACC and LAAC patient selection criteria.
- Assess the cost-effectiveness, efficacy and safety of LAAC therapy.
- Evaluate optimal LAAC clinical decision making strategies and procedural approaches.
- Examine catheter ablation with LAAC, including patient selection, clinical workflow and outcomes.
- Assess clinical outcomes and practical aspects of LACC.
SPAF 2017
On-Demand Video Presentations from 2017 SPAF
Complimentary Access
We are pleased to provide complimentary and unlimited access to the on-demand video library from the 2017 Symposium on Stroke Prevention in Atrial Fibrillation Advancements in Oral Anticoagulation Therapy and LAA Closure. The presentation format consists of synched audio and video, along with the presenters slides.
Access 2017 Live Cases and presentations
 |
 |
 |